{
    "Trade/Device Name(s)": [
        "Virtuoso\u2122M System for IHC PR (1E2)",
        "Virtuoso System For IHC PR (1E2) Benchmark ULTRA Stainer"
    ],
    "Submitter Information": "Ventana Medical Systems, Inc.",
    "510(k) Number": "K122143",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111869"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOT",
        "NQN",
        "OEO"
    ],
    "Summary Letter Date": "August 21, 2013",
    "Summary Letter Received Date": "August 22, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "immunology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "Progesterone Receptor (PR) protein"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded tissue"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "Ventana iScan slide scanner",
        "Benchmark ULTRA stainer",
        "Computer",
        "Monitor",
        "Keyboard",
        "Mouse"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry",
        "Digital pathology",
        "Image analysis",
        "Computer-assisted image quantification"
    ],
    "Methodologies": [
        "Immunohistochemical staining",
        "Digital image analysis",
        "Semi-quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Accessory",
        "Software",
        "Instrument",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Virtuoso System for IHC PR (1E2) Benchmark ULTRA stainer for digital pathology image analysis of immunohistochemically stained breast cancer tissue sections",
    "Indications for Use Summary": "Intended as an aid to the pathologist in the detection and semi-quantitative measurement of progesterone receptor protein in formalin-fixed, paraffin-embedded normal and neoplastic tissue, as an accessory to the CONFIRMTM anti-Progesterone Receptor (PR) (1E2) Rabbit Monoclonal Primary Antibody assay, supporting assessment of breast cancer patients for endocrine treatment consideration",
    "fda_folder": "Hematology"
}